Investors including Quadria Capital and Denmark-based pharmaceutical major Novo Nordisk are among those interested in a minority stake and engaged in early discussions, they said. In February, Novo Holdings, the holding company of Novo Nordisk, acquired US-based publicly-listed contract development and manufacturing organisation Catalent for $16.5 billion.
India, Taiwan ETFs see record outflows before Asia stock rebound
US-listed ETFs tracking India and Taiwan saw record outflows in March amid currency weakness, rising yields and energy concerns. Despite this, Asian equities rebounded sharply